Clin2
NCT07871097Possibly a fitRecruiting

Rimegepant for acute vestibular migraine relief

Vestibular Migraine

This study tests a medication called rimegepant to see if it quickly relieves vertigo and dizziness during a vestibular migraine attack. Vestibular migraine causes symptoms like spinning or imbalance, often with headache. If you have frequent, moderate-to-severe episodes, this treatment might offer relief.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
80 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You have been diagnosed with vestibular migraine by a doctor, using specific criteria.
  • You have had at least 4 vestibular migraine attacks in the past year, each lasting over 2 hours and being moderate to severe.
  • You do not have other conditions that cause vertigo, like Ménière's disease or ear infections.
  • You are able to clearly tell the difference between your vestibular migraine attacks and any other dizziness you might have (like from anxiety).
  • You do not have severe liver or kidney problems, or severe heart or blood vessel disease.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06748664Not yet recruiting· Phase 2
Rimegepant for vestibular migraine

This trial tests whether rimegepant, a medicine usually used for migraine headaches, can help reduce dizziness attacks in people with vestibular migraine. If you have frequent dizziness and have not found enough relief from other preventive treatments, this study may be an option.

NCT07751497Not yet recruiting· Phase 2
Comparing two medicines to prevent dizziness in vestibular migraine

This study compares two oral medications—rimegepant and flunarizine—to see how well they prevent dizzy or vertigo episodes in people with vestibular migraine. You will take one of the two medicines daily for several months, and track your symptoms on a smartphone app.

Hangzhou, Zhejiang
NCT07203248Not yet recruiting
Real-world study for people with vestibular migraine

This study will track how current treatments work for adults with vestibular migraine, a condition where migraine causes dizziness and balance problems. It may help doctors learn which options help most in everyday life.

NCT07435090Not yet recruiting· Phase 2/Phase 3
Rimegepant for sudden dizzy spells with migraine symptoms

This study tests a medication called rimegepant (a CGRP blocker) as a treatment for sudden dizziness attacks that come with migraine-like symptoms. If you have these kinds of dizzy spells, this trial may help find out if the drug can stop them quickly.

NCT07729462Recruiting· Phase 3
Rimegepant for preventing chronic migraine

This study tests whether the medication rimegepant can help prevent chronic migraine in adults. It may be an option if you have frequent migraines and have not tried certain other preventive treatments.

Scottsdale, Arizona
NCT06728345Not yet recruiting
Rimegepant for preventing migraines in women

This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.

Hear when a new Vestibular Migraine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.